Spanish Academy of Dermatology and Venereology (AEDV) Melanoma Registry
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Melanoma. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Spain
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Registro de Melanoma de la AEDV
Overview
The goal of this patient registry is to describe risk factors for bad prognosis of melanoma in Spain. The main questions it aims to answer are: * To describe socioeconomical individual risk factors associated with melanoma prognosis, such as gender, residence area or socioeconomic level. * To describe potentially modifiable characteristics of health care associated with prognosis, such as waiting times, type of centre that makes the diagnosis or use of teledermatology Participants data will be gathered for analysis, without any change in the way that they are being treated.
Primary outcome measures
- AJCC (American Joint Committee on Cancer) TNM stage (Tumor, node, metastasis) [Time frame: 1 day At diagnosis]
- Breslow thickness [Time frame: 1 day At diagnosis]
Secondary outcome measures (2)
- Time to progression [Time frame: through study completion, an average of 3 years]
- Survival [Time frame: through study completion, an average of 3 years]
Eligibility criteria
Inclusion criteria
- All consecutive patients with a diagnosis of invasive primary cutaneous melanoma in participating centres.
Exclusion criteria
- In-situ melanomas
- non-cutaneous melanomas,
- metastatic melanoma with unknown primary site.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Spain · 21 centers
- Hospital Universitari Germans Trias i Pujol — Badalona
- Complexo Hospitalario Universitario de A Coruña — A Coruña
- Hospital Clinic — Barcelona
- Hospital San Juan de Dios — Córdoba
- Hospital Universitario de Gran Canaria Dr Negrín — Las Palmas
- Complejo Asistencial Universitario de León — León
- Clínica Dermatológica Internacional — Madrid
- Clínica Universitaria de Navarra ( sede de Madrid) — Madrid
- … and 13 more centers
Identifiers
NCT: NCT05673681 · FAE-MEL-2022-01